Recombinant Rat Calcitonin/CALCA Protein, Two N- s, His- & SUMO-

Calcitonin, a peptide hormone produced by the parafollicular cells of the thyroid gland, plays a crucial role in calcium homeostasis, primarily by inhibiting osteoclast activity and reducing bone resorption. The discovery of the CALCA gene, which encodes calcitonin and its related peptides, has spurred interest in understanding its biological functions and therapeutic potential. Research has demonstrated that calcitonin can be beneficial in treating osteoporosis and related bone disorders by decreasing the risk of fractures. Furthermore, its analgesic properties have garnered attention for potential applications in pain management, particularly in conditions such as arthritis and certain cancer-related pain. The recombinant production of calcitonin and CALCA-derived proteins allows for detailed study and potential clinical applications. These recombinant proteins offer advantages in terms of purity, consistency, and scalability, facilitating research into their mechanisms of action and efficacy. As scientists explore the multifaceted roles of calcitonin, including its interactions with other signaling pathways and cellular processes, the development of novel therapeutic strategies is on the horizon, harnessing the potential benefits of this hormone in regenerative medicine and orthopedic treatments.